Management strategies for idiopathic intracranial hypertension

References

• Friedman DI, Liu GT, Digree KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 2013;81:1159-65
   PubMed Web of Science ®Google Scholar
• Digre KB. Not so benign intracranial hypertension. BMJ 2003;326(7390):613-14
   PubMedGoogle Scholar
• Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri. population studies in Iowa and Louisiana. Arch Neurol 1988;45(8):875-7
   PubMedGoogle Scholar
• Digre KB, Corbett JJ. Idiopathic intracranial hypertension (pseudotumor cerebri): a reappraisal. Neurologist 2001;7(1):2-67
   Web of Science ®Google Scholar
• Biousse V, Bruce BB, Newman NJ. Update on the pathophysiology and management of idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 2012;83(5):488-94
   PubMed Web of Science ®Google Scholar
• Friedman DI. Pseudotumor cerebri presenting as headache. Expert Rev Neurother 2008;8(3):397-407
   PubMedGoogle Scholar
• Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders: 2nd edition. Cephalalgia 2004;24(Suppl 1):9-160
   PubMed Web of Science ®Google Scholar
• Lueck CJ, McIlwaine GG. Interventions for idiopathic intracranial hypertension. Cochrane Database Syst Rev 2005;3:CD003434
   Google Scholar
• Friesner D, Rosenman R, Lobb BM, Tanne E. Idiopathic intracranial hypertension in the USA: the role of obesity in establishing prevalence and healthcare costs. Obes Rev 2011;12(5):e372-80
   Google Scholar
• Szewka AJ, Bruce BB, Newman NJ, Biousse V. Idiopathic intracranial hypertension: relation between obesity and visual outcomes. J Neuroophthalmol 2013;33(1):4-8
   PubMed Web of Science ®Google Scholar
• Skau M, Sander B, Milea D, Jensen R. Disease activity in idiopathic intracranial hypertension: a 3-month follow-up study. J Neurol 2011;258:277-83
   PubMed Web of Science ®Google Scholar
• Newborg B. Pseudotumor cerebri treated by rice reduction diet. Arch Intern Med 1974;133(5):802-7
   PubMedGoogle Scholar
• Johnson LN, Krohel GB, Madsen RW, March GA Jr. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology 1998;105(12):2313-17
   PubMed Web of Science ®Google Scholar
• Sinclair AJ, Burdon MA, Nightingale PG, et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ 2010;341:c2701
   PubMed Web of Science ®Google Scholar
• Yri HM, Wegener M, Sander B, Jensen R. Idiopathic intracranial hypertension is not benign: a long-term outcome study. J Neurol 2012;259:886-94
   PubMed Web of Science ®Google Scholar
• Warner JE, Larson AJ, Bhosale P, et al. Retinol-binding protein and retinol analysis in cerebrospinal fluid and serum of patients with and without idiopathic intracranial hypertension. J Neuroophthalmol 2007;27:258-62
   PubMed Web of Science ®Google Scholar
• Johnson LN. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension. Ophthalmology 1998;105:2313
   PubMed Web of Science ®Google Scholar
• Kesler A, Hadayer A, Goldhammer Y, et al. Idiopathic intracranial hypertension: risk of recurrences. Neurology 2004;63:1737-9
   PubMed Web of Science ®Google Scholar
• Gücer G, Viernstein L. Long-term intracranial pressure recording in the management of pseudotumor cerebri. J Neurosurg 1978;49(2):256
   PubMed Web of Science ®Google Scholar
• Ball AK, Howman A, Wheatley K, et al. A randomized controlled trial of treatment for idiopathic intracranial hypertension. J Neurol 2011;258(5):874-81
   PubMed Web of Science ®Google Scholar
• Lee AG, Wall M. Papilledema: are we any nearer to a consensus on pathogenesis and treatment? Curr Neurol Neurosci Rep 2012;12(3):34-9
   PubMed Web of Science ®Google Scholar
• Buhrley LE, Reed DJ. The effect of furosemide on sodium-22 uptake into cerebrospinal fluid and brain. Exp Brain Res 1972;14(5):503-10
   PubMed Web of Science ®Google Scholar
• McCarthy KD, Reed DJ. The effect of acetazolamide and furosemide on CSF production and choroid plexus carbonic anhydrase activity. J Pharmacol Exp Ther 1974;189:94-201
   Web of Science ®Google Scholar
• Schoeman JF. Childhood pseudotumor cerebri: clinical and intracranial pressure response to acetazolamide and furosemide treatment in a case series. J Child Neurol 1994;9(2):30-134
   Web of Science ®Google Scholar
• Alore PL, Jay WM, Macken MP. Topiramate, pseudotumor cerebri, weight-loss and glaucoma: an ophthalmologic perspective. Semin Ophthalmol 2006;21:15-17
   PubMedGoogle Scholar
• Finsterer J, Földy D, Fertl E. Topiramate resolves headache from pseudotumor cerebri. J Pain Symptom Manage 2006;32:401-2
   PubMed Web of Science ®Google Scholar
• Marmura MJ, Hopkins M, Andrel J, et al. Electronic medical records as a research tool: evaluating topiramate use at a headache center. Headache 2010;50:769-78
   PubMed Web of Science ®Google Scholar
• Thurtell MJ, Wall M. Idiopathic intracranial hypertension (pseudotumor cerebri): recognition, treatment, and ongoing management. Curr Treat Options Neurol 2013;15(1):1-12
   PubMed Web of Science ®Google Scholar
• Pagan FL, Restrepo L, Balish M, et al. A new drug for an old condition? Headache 2002;42:695-6
   PubMed Web of Science ®Google Scholar
• Celebisoy N, Gokcay F, Sirin H, Akyurekli O. Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand 2007;116:322-7
   PubMed Web of Science ®Google Scholar
• Shah VA, Fung S, Shahbaz R, et al. Letter to the editor idiopathic intracranial hypertension. Ophthalmology 2007;114(3):617.e1-2
   Web of Science ®Google Scholar
• Deftereos SN, Panagopoulos G, Georgonikou D, et al. Treatment of idiopathic intracranial hypertension: is there a place for octreotide? Cephalalgia 2011;31:679-1680
   Web of Science ®Google Scholar
• Panagopoulos GN, Deftereos SN, Tagaris GA, et al. Octreotide: a therapeutic option for idiopathic intracranial hypertension. Neurol Neurophysiol Neurosci 2007;1
   Google Scholar
• Corbett JJ, Thompson HS. The rational management of idiopathic intracranial hypertension. Arch Neurol 1989;46:1049-51
   PubMed Web of Science ®Google Scholar
• Thambisetty M, Lavin PJ, Newman NJ, Biousse V. Fulminant idiopathic intracranial hypertension. Neurology 2007;68(3):229-32
   PubMed Web of Science ®Google Scholar
• Digre KB, Varner MW, Corbett JJ. Pseudotumor cerebri and pregnancy. Neurology 1984;34:721-9
   PubMed Web of Science ®Google Scholar
• Huna-Baron R, Kupersmith MJ. Idiopathic intracranial hypertension in pregnancy. J Neurol 2002;249:1078-81
   PubMed Web of Science ®Google Scholar
• Friedman DI, Rausch EA. Headache diagnoses in patients with treated idiopathic intracranial hypertension. Neurology 2002;58(10):1551-3
   PubMed Web of Science ®Google Scholar
• Obana WG, Raskin NH, Cogen PH, et al. Antimigraine treatment for slit ventricle syndrome. Neurosurgery 1990;27:760-3
   PubMed Web of Science ®Google Scholar
• James HE, Nowak TP. Clinical course and diagnosis of migraine headaches in hydrocephalic children. Pediatr Neurosurg 199117:310-16
   PubMed Web of Science ®Google Scholar
• Brazis PW. Clinical review: the surgical treatment of idiopathic pseudotumour cerebri (idiopathic intracranial hypertension). Cephalalgia 2008;28(12):1361-73
   PubMed Web of Science ®Google Scholar
• El-Saadany WF, Farhoud A, Zidan I. Lumboperitoneal shunt for idiopathic intracranial hypertension: patients’ selection and outcome. Neurosurg Rev 2012;35:239-43
   PubMed Web of Science ®Google Scholar
• Spitze A, Malik A, Lee AG. Surgical and endovascular interventions in idiopathic intracranial hypertension. Curr Opin Neurol 2014;27(1):69-74
   PubMed Web of Science ®Google Scholar
• Sinclair AJ, Kuruvath S, Sen D, et al. Is cerebrospinal fluid shunting in idiopathic intracranial hypertension worthwhile? a 10-year review. Cephalalgia 2011;31:1627-33
   PubMed Web of Science ®Google Scholar
• Feldon SE. Visual outcomes comparing surgical techniques for management of severe idiopathic intracranial hypertension. Neurosurg Focus 2007;23:E6
   Google Scholar
• Abubaker K, Ali Z, Raza K, et al. Idiopathic intracranial hypertension: lumboperitoneal shunts versus ventriculoperitoneal shunts–case series and literature review. Br J Neurosurg 2011;25:94-9
   PubMed Web of Science ®Google Scholar
• McGirt MJ, Woodworth G, Thomas G, et al. Cerebrospinal fluid shunt placement for pseudotumor cerebri-associated intractable headache: predictors of treatment response and an analysis of long-term outcomes. J Neurosurg 2004;101:627-32
   PubMed Web of Science ®Google Scholar
• Yadav YR, Parihar V, Agarwal M, et al. Lumbar peritoneal shunt in idiopathic intracranial hypertension. Turk Neurosurg 2012;22:21-6
   PubMed Web of Science ®Google Scholar
• Galgano MA, Deshaies EM. An update on the management of pseudotumor cerebri. Clin Neurol Neurosurg 2013;115:252-9
   PubMed Web of Science ®Google Scholar
• Tarnaris A, Toma AK, Watkins LD, Kitchen ND. Is there a difference in outcomes of patients with idiopathic intracranial hypertension with the choice of cerebrospinal fluid diversion site: a single centre experience. Clin Neurol Neurosurg 2011;113:477-9
   PubMed Web of Science ®Google Scholar
• Toma AK, Dherijha M, Kitchen ND, Watkins LD. Use of lumboperitoneal shunts with the Strata NSC valve: a single-centre experience. J Neurosurg 2010;113(6):1304-8
   PubMed Web of Science ®Google Scholar
• Banta JT, Farris BK. Pseudotumor cerebri and optic nerve sheath decompression. Ophthalmology 2000;107:1907-12
   PubMed Web of Science ®Google Scholar
• Acheson JF, Green WT, Sanders MD. Optic nerve sheath decompression for the treatment of visual failure in chronic raised intracranial pressure. J Neurol Neurosur Psychiatry 1994;57:1426-9
   PubMed Web of Science ®Google Scholar
• Friedman D, Jacobson D. Diagnostic criteria for idiopathic intracranial hypertension. Neurology 2002;59:1492-5
   PubMed Web of Science ®Google Scholar
• Plotnik J, Kosmorsky G. Operative complications of optic nerve sheath decompression. Ophthalmology 1993;100:683-90
   PubMed Web of Science ®Google Scholar
• Spitze A, Malik A, Al-Zubidi N, et al. Optic nerve sheath fenestration vs cerebrospinal diversion procedures: what is the preferred surgical procedure for the treatment of idiopathic intracranial hypertension failing maximum medical therapy? J Neuroophthalmol 2013;33:83-188
   Web of Science ®Google Scholar
• Sinclair AJ, Burdon MA, Nightingale PG, et al. Rating papilloedema: an evaluation of the Frisen classification in idiopathic intracranial hypertension. J Neurol 2012;259:406-1412
   Web of Science ®Google Scholar
• Sergott RC, Savino PJ, Bosley TM. Modified optic nerve sheath decompression provides long-term visual improvement for pseudotumor cerebri. Arch Ophthalmol 1988;106(10):384-90
   Google Scholar
• Keltner JL. Optic nerve sheath decompression. Arch Ophthalmol 1988;106:1365-9
   PubMedGoogle Scholar
• Moreau A, Lao KC, Farris BK. Optic nerve sheath decompression: a surgical technique with minimal operative complications. J Neuroophthalmol 2014;34(1):34-8
   PubMed Web of Science ®Google Scholar
• Chandrasekaran S, McCluskey P, Minassian D, Assaad N. Visual outcomes for optic nerve sheath fenestration in pseudotumour cerebri and related conditions. Clin Experiment Ophthalmol 2006;34:661-5
   PubMed Web of Science ®Google Scholar
• Kelman SE, Sergott RC, Cioffi GA, et al. Modified optic nerve decompression in patients with functioning lumboperitoneal shunts and progressive visual loss. Ophthalmology 1991;98:1449-53
   PubMed Web of Science ®Google Scholar
• Batra R, Sinclair A. Idiopathic intracranial hypertension; research progress and emerging themes. J Neurol 2014;261(3):451-60
   PubMed Web of Science ®Google Scholar
• Bussière M, Falero R, Nicolle D, et al. Unilateral transverse sinus stenting of patients with idiopathic intracranial hypertension. AJNR Am J Neuroradiol 2010;31:645-50
   PubMed Web of Science ®Google Scholar
• Ahmed RM, Wilkinson M, Parker GD, et al. Transverse sinus stenting for idiopathic intracranial hypertension: a review of 52 patients and of model predictions. AJNR Am J Neuroradiol 2011;32(8):1408-14
   PubMed Web of Science ®Google Scholar
• Puffer RC, Mustafa W, Lanzino G. Venous sinus stenting for idiopathic intracranial hypertension: a review of the literature. J Neurointerv Surg 2013;5(5):483-6
   PubMed Web of Science ®Google Scholar
• Albuquerque FC, Dashti SR, Hu YC, et al. Intracranial venous sinus stenting for benign intracranial hypertension: clinical indications, technique, and preliminary results. World Neurosurg 2011;75(5-6):648-52
   PubMed Web of Science ®Google Scholar
• Kumpe DA, Bennett JL, Seinfeld J, et al. Dural sinus stent placement for idiopathic intracranial hypertension. J Neurosurg 2012;116:538-48
   PubMed Web of Science ®Google Scholar
• Riggeal BD, Bruce BB, Saindane AM, et al. Clinical course of idiopathic intracranial hypertension with transverse sinus stenosis. Neurology 2013;80:289-95
   PubMed Web of Science ®Google Scholar
• Ogungbo B, Roy D, Gholkar A, Mendelow AD. Endovascular stenting of the transverse sinus in a patient presenting with benign intracranial hypertension. Br J Neurosurg 2003;17:565-8
   PubMed Web of Science ®Google Scholar
• Sugerman HJ, FeltonIII, WL, et al. Gastric surgery for pseudotumor cerebri associated with severe obesity. Ann Surg 1999;229:634-40
   PubMed Web of Science ®Google Scholar
• Mei QY, Xiao WZ, Chen HR, et al. Which is the best peri-operative anticoagulative therapy of transverse sinus stenting for refractory idiopathic intracranial hypertension? Chin Med J 2012;125:2951-3
   PubMed Web of Science ®Google Scholar
• Paquet C, Poupardin M, Boissonnot M, et al. Efficacy of unilateral stenting in idiopathic intracranial hypertension with bilateral venous sinus stenosis: a case report. Eur Neurol 2008;60:47-8
   PubMed Web of Science ®Google Scholar
• Chandra V, Dutta S, Albanese CT, et al. Clinical resolution of severely symptomatic pseudotumor cerebri after gastric bypass in an adolescent. Surg Obes Relat Dis 2007;3:98-200
   Web of Science ®Google Scholar
• Nadkarni T, Rekate HL, Wallace D. Resolution of pseudotumor cerebri after bariatric surgery for related obesity. Case report. J Neurosurg 2004;101:878-80
   PubMed Web of Science ®Google Scholar
• Bruce BB, Kedar S, Van Stavern GP, et al. Idiopathic intracranial hypertension in men. Neurology 2009;72:304-9
   PubMed Web of Science ®Google Scholar
• Ko MW, Chang SC, Ridha MA, et al. Weight gain and recurrence in idiopathic intracranial hypertension: a case-control study. Neurology 2011;76:1564-7
   PubMed Web of Science ®Google Scholar
• Fridley J, Foroozan R, Sherman V, et al. Bariatric surgery for the treatment of idiopathic intracranial hypertension. J Neurosurg 2011;114:34-9
   PubMed Web of Science ®Google Scholar
• Dandy WE. Intracranial pressure without brain tumor: diagnosis and treatment. Ann Surg 1973;106:492-513
   Google Scholar
• Kessler LA, Novelli PM, Reigel DH. Surgical treatment of benign intracranial hypertension – subtemporal decompression revisited. Surg Neurol 1998;50:73-6
   PubMedGoogle Scholar
• Klekamp J. Surgical treatment of Chiari I malformation – analysis of intraoperative findings, complications, and outcome for 371 foramen magnum decompressions. Neurosurgery 2012;71:365-80
   PubMed Web of Science ®Google Scholar
• Klekamp J. Neurological deterioration after foramen magnum decompression for Chiari malformation type I: old or new pathology? J Neurosurg Pediatr 2012;10:538-47
   PubMed Web of Science ®Google Scholar
• Vaphiades MS, Eggenberger ER, Miller NR, et al. Resolution of papilledema after neurosurgical decompression for primary Chiari I malformation. Am J Ophthalmol 2002;133:673-8
   PubMed Web of Science ®Google Scholar
• Clinicaltrials.gov. Idiopathic Intracranial Hypertension Treatment Trial (IIHTT). Available from: http://clinicaltrials.gov/show/NCT01003639
   Google Scholar
• ClinicalTrials.gov. Venous sinus stenting for idiopathic intracranial hypertension. Available from: http://clinicaltrials.gov/ct2/show/NCT01407809
   Google Scholar